Showing 20 of 76 recruiting trials for “Idiopathic pulmonary fibrosis”
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingNCT07312305 ↗
Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF)
Downhill Walking in IPF
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
A Trial of HRS-9813 in Healthy Subjects
SB17170 Phase 2 Trial in IPF Patients
Advanced Imaging for Pulmonary Fibrosis
RecruitingNCT07174102 ↗
Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography
RecruitingNCT06162884 ↗
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
👨⚕️ Samuel Weigt, MD, UCLA Division of Pulmonary, Critical Care, and Hospitals📍 1 site📅 Started Nov 2024View details ↗
Routine vs On-demand ECMO for Lung Transplantation
RecruitingNCT06909409 ↗
D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis
Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
👨⚕️ Marlies S. Wijsenbeek-Lourens, Prof Dr, Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center, Rotterdam, The Netherlands📍 11 sites📅 Started Oct 2024View details ↗
Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context
Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis
👨⚕️ Chan Beals, MD, PhD, Calibr-Skaggs Institute for Innovative Medicines📍 1 site📅 Started Aug 2024View details ↗
Enrolling by InvitationNCT06629623 ↗
Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers
RecruitingNCT06323876 ↗
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
RecruitingNCT06445686 ↗
Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →